Literature DB >> 17485439

Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.

Shin Usami1, Takuya Moriya, Masakazu Amari, Akihiko Suzuki, Takanori Ishida, Hironobu Sasano, Noriaki Ohuchi.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the reliability of information obtained by core needle biopsy (CNB).
METHODS: We studied 111 women (112 lesions) with breast cancer who underwent CNB and subsequent surgical excision. Six factors (histological type, nuclear grade, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor-2 (HER2) status) were evaluated in a blinded fashion at CNB and at surgical excision.
RESULTS: The histological type at CNB correlated exactly with that of the excisional specimen in 83% (87/105) of the cases. Of the 45 in situ lesions at CNB, 16 (36%) were found to have invasive carcinoma at surgical excision. The difference between the specimens from CNB and those from surgery in terms of the absolute concordance rate and kappa statistic value were 61% with a fair kappa value (0.26) in the nuclear grade, 75% with a moderate kappa value (0.55) in the histological grade, 95% with an almost perfect kappa value (0.84) in ER, 88% with a substantial kappa value (0.70) in PR and 88% with a substantial kappa value (0.65) in HER2. Regarding the evaluation of nuclear and histological grades, a trend toward greater accuracy was observed when thicker specimens were used.
CONCLUSIONS: CNB provided reliable information on the histological type of invasive carcinoma. It also evaluated ER, PR and HER2 (only in cases where the score was 3+) accurately in spite of the limited quantity of the specimen obtained with the thin (16-gauge) needle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485439     DOI: 10.1093/jjco/hym021

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  17 in total

Review 1.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

2.  Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant Radiotherapy.

Authors:  Christoph Thomssena; Nadia Harbeckb
Journal:  Breast Care (Basel)       Date:  2010-08-20       Impact factor: 2.860

3.  Are biopsy specimens predictive of HER2 status in gastric cancer patients?

Authors:  M Pirrelli; M L Caruso; M Di Maggio; R Armentano; A M Valentini
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

4.  Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.

Authors:  Jie Chen; Zu Wang; Qing Lv; Zhenggui Du; Qiuwen Tan; Di Zhang; Bingjun Xiong; Helin Zeng; Juxiang Gou
Journal:  Pathol Oncol Res       Date:  2017-01-10       Impact factor: 3.201

5.  Problems In Determining Her2 Status In Breast Carcinoma.

Authors:  Emel Ebru Pala; Ümit Bayol; Alp Özgüzer; Ülkü Küçük; Çağlar Yıldız Akdeniz; Özlem Sezer
Journal:  J Breast Health       Date:  2015-01-01

6.  Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1-2 positive sentinel lymph nodes.

Authors:  Lei Meng; Ting Zheng; Yuanyuan Wang; Zhao Li; Qi Xiao; Junfeng He; Jinxiang Tan
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

7.  HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens.

Authors:  Hitoshi Tsuda; Masafumi Kurosumi; Shinobu Umemura; Sohei Yamamoto; Takayuki Kobayashi; Robert Yoshiyuki Osamura
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

8.  Reliability of receptor assessment on core needle biopsy in breast cancer patients.

Authors:  S C Seferina; M Nap; F van den Berkmortel; J Wals; A C Voogd; V C G Tjan-Heijnen
Journal:  Tumour Biol       Date:  2012-12-27

9.  Accuracy of prognostic and predictive markers in core needle breast biopsies compared with excisional specimens.

Authors:  Mohammad Motamedolshariati; Bahram Memar; Mohsen Aliakbaian; Mohammad T Shakeri; Mohammad Samadi; Ali Jangjoo
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

Review 10.  Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.

Authors:  Nicola Fusco; Moira Ragazzi; Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Stefania Morganti; Giacomo Santandrea; Giuseppe Nicolò Fanelli; Luca Despini; Marco Invernizzi; Bruna Cerbelli; Cristian Scatena; Carmen Criscitiello
Journal:  Histol Histopathol       Date:  2021-09-29       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.